Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet

Metabolism: Clinical and Experimental

Volumn 60, Issue 5, 2011, Pages 617-628

  Muraoka, Tomonori ^a   Aoki, Kazutaka ^a   Iwasaki, Tomoyuki ^a   Shinoda, Kazuaki ^a   Nakamura, Akinobu ^a   Aburatani, Hiroyuki ^b   Mori, Shuuichi ^c   Tokuyama, Kumpei ^c   Kubota, Naoto ^d   Kadowaki, Takashi ^d   Terauchi, Yasuo ^a  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; BILE ACID; EZETIMIBE; INSULIN RECEPTOR SUBSTRATE 2; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN KINASE B; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHOLESTEROL LIVER LEVEL; DNA MICROARRAY; DOWN REGULATION; DRUG EFFECT; FATTY LIVER; GENE EXPRESSION; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; LIPID METABOLISM; LIVER CELL; LIVER WEIGHT; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; UPREGULATION;

ADIPOSITY; ANIMALS; ANTICHOLESTEREMIC AGENTS; AZETIDINES; BILE ACIDS AND SALTS; CELLS, CULTURED; CHOLESTEROL, LDL; DIETARY FATS; FATTY LIVER; GLUCOSE; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; LIVER; MALE; MICE; MICE, INBRED C57BL; PROTO-ONCOGENE PROTEINS C-AKT; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; TRIGLYCERIDES;

EID: 79955018542     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2010.06.008     Document Type: Article

References (38)

1. Altmann S.W., Davis H.R., Zhu L.J., Yao X., Hoos L.M., and Tetzloff G. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption Science 303 2004 1201 1204 (Pubitemid 38233587)
2. Davies J.P., Scott C., Oishi K., Liapis A., and Ioannou Y.A. Inactivation of NPC1L1 causes multiple lipid transport defects and protects against diet-induced hypercholesterolemia J Biol Chem 280 2005 12710 12720
3. Valasek M.A., Repa J.J., Quan G., Dietschy J.M., and Turley S.D. Inhibiting intestinal NPC1L1 activity prevents diet-induced increase in biliary cholesterol in Golden Syrian hamsters Am J Physiol Gastrointest Liver Physiol 295 2008 813 822
4. Deushi M., Nomura M., Kawakami A., Haraguchi M., Ito M., and Okazaki M. Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome FEBS Lett 581 2007 5664 5670 (Pubitemid 350179776)
5. Labonté E.D., Camarota L.M., Rojas J.C., Jandacek R.J., Gilham D.E., and Davies J.P. Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and Npc1l1-/- mice Am J Physiol Gastrointest Liver Physiol 295 2008 776 783
6. Assy N., Grozovski M., Bersudsky I., Szvalb S., and Hussein O. Effect of insulin-sensitizing agents in combination with ezetimibe, and valsartan in rats with non-alcoholic fatty liver disease World J Gastroenterol 12 2006 4369 4376 (Pubitemid 44194531)
7. Zheng S., Hoos L., Cook J., Tetzloff G., Davis H. Jr, and van Heek M. Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice Eur J Pharmacol 584 2008 118 124
8. Knopp R.H., Dujovne C.A., Beaut A.L., Lipka L.J., Suresh R., and Veltri E.P. Evaluation of the efficacy, safety, and tolerability of ezetimibe in primary hypercholesterolaemia: a pooled analysis from two controlled phase III clinical studies Int J Clin Pract 57 2003 363 368 (Pubitemid 36798442)
9. Browning J.D., and Horton J.D. Molecular mediators of hepatic steatosis and liver injury J Clin Invest 114 2004 147 152 (Pubitemid 39071617)
10. González-Ortiz M., Martínez-Abundis E., Kam-Ramos A.M., Hernández-Salazar E., and Ramos-Zavala M.G. Effect of ezetimibe on insulin sensitivity and lipid profile in obese and dyslipidaemic patients Cardiovasc Drug Ther 20 2006 143 146 (Pubitemid 43876098)
11. Davis H.R. Jr, Compton D.S., Hoos L., and Tetzloff G. Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in ApoE knockout mice Arterioscler Thromb Vasc Biol 21 2001 2032 2038 (Pubitemid 34219758)
12. Folch J., Lees M., and Sloane Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues J Biol Chem 226 1957 497
13. Usui S., Hara Y., Hosaki S., and Okazaki M. A new on-line dual enzymatic method for simultaneous quantification of cholesterol and triglycerides in lipoproteins by HPLC J Lipid Res 43 2002 805 814 (Pubitemid 34477908)
14. Udagawa H., Kitaoka C., Sakamoto T., Kobayashi-Hattori K., Oishi Y., and Arai S. Serum cholesterol-decreasing effect of heat-moisture-treated high-amylose cornstarch in cholesterol-loaded rats Biosci Biotechnol Biochem 72 2008 880 884 (Pubitemid 351463688)
15. Terauchi Y., Takamoto I., Kubota N., Matsui J., Suzuki R., and Komeda K. Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance J Clin Invest 117 2007 246 257 (Pubitemid 46048470)
16. Aoki K., Matsui J., Kubota N., Nakajima H., Iwamoto K., and Takamoto I. The role of the liver in glucose homeostasis in PI 3-kinase p85α deficient mice Am J Physiol Endocrinol Metab 296 2009 E842 E853
17. Kubota N., Terauchi Y., Kubota T., Kumagai H., Itoh S., and Satoh H. Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways J Biol Chem 281 2006 8748 8755 (Pubitemid 43847980)
18. Suzuki R., Tobe K., Aoyama M., Inoue A., Sakamoto K., and Yamauchi T. Both insulin signaling defects in the liver and obesity contribute to insulin resistance and cause diabetes in Irs2(-/-) mice J Biol Chem 279 2004 25039 25049 (Pubitemid 38756752)
19. Kubota N., Terauchi Y., Tobe K., Yano W., Suzuki R., Ueki K., and Takamoto I. Insulin receptor substrate 2 plays a crucial role in beta cells and the hypothalamus J Clin Invest 114 2004 917 927 (Pubitemid 39578719)
20. Berry M.N., and Friend D.S. High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study J Cell Biol 43 1969 506 520
21. Seglen P.O. Incorporation of radioactive amino acids into protein in isolated rat hepatocytes Biochim Biophys Acta 442 1976 391 404
22. Shiroyama K., Moriwaki K., and Yuge O. The direct effect of dopamine on glucose release from primary cultured rat hepatocytes In Vivo 12 1998 527 529 (Pubitemid 28517698)
23. Zhang G., Budker V., and Wolff J.A. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA Hum Gene Ther 10 1999 1735 1737 (Pubitemid 29328217)
24. Bisbis S., Bailbe D., Tormo M.A., Picarel-Blanchot F., Derouet M., and Simon J. Insulin resistance in the GK rat: decreased receptor number but normal kinase activity in liver Am J Physiol 265 1993 807 813
25. Song E., Lee S.K., Wang J., Ince N., Ouyang N., and Min J. RNA interference targeting Fas protects mice from fulminant hepatitis Nat Med 9 2003 226 227
26. McCaffrey A.P., Meuse L., Pham T.T., Conklin D.S., Hannon G.J., and Kay M.A. RNA interference in adult mice Nature 418 2002 38 39 (Pubitemid 34742563)
27. Lewis D.L., Hagstrom J.E., Loomis A.G., Wolff J.A., and Herweijer H. Efficient delivery of siRNA for inhibition of gene expression in postnatal mice Nat Genet 32 2002 107 108 (Pubitemid 34977204)
28. Watanabe M., Houten S.M., Wang L., Moschetta A., Mangelsdorf D.J., and Heyman R.A. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c J Clin Invest 113 2004 1408 1418 (Pubitemid 39071696)
29. Ide T., Shimano H., Yahagi N., Matsuzaka T., Nakakuki M., and Yamamoto T. SREBPs suppress IRS-2-mediated insulin signalling in the liver Nat Cell Biol 6 2004 351 357 (Pubitemid 38584825)
30. Yamagata K., Daitoku H., Shimamoto Y., Matsuzaki H., Hirota K., and Ishida J. Bile acids regulate gluconeogenic gene expression via small heterodimer partner-mediated repression of hepatocyte nuclear factor 4 and Foxo1 J Biol Chem 279 2004 23158 23165 (Pubitemid 38685621)
31. Kamei Y., Miura S., Suganami T., Akaike F., and Kanai S. Regulation of SREBP1c gene expression in skeletal muscle: role of retinoid X receptor/liver X receptor and forkhead-O1 transcription factor Endocrinology 149 2008 2293 2305 (Pubitemid 351577397)
32. Goodwin B., Jones S.A., Price R.R., Watson M.A., McKee D.D., and Moore L.B. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis Mol Cell 6 2000 517 526
33. Lu T.T., Makishima M., Repa J.J., Schoonjans K., Kerr T.A., and Auwerx J. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors Mol Cell 6 2000 507 515
34. Russell D.W., and Setchell K.D. Bile acid biosynthesis Biochemistry 31 1992 4737 4749
35. Repa J.J., Turley S.D., Quan G., and Dietschy J.M. Delineation of molecular changes in intrahepatic cholesterol metabolism resulting from diminished cholesterol absorption J Lipid Res 46 2005 779 789 (Pubitemid 43073288)
36. Mathur A., Walker J.J., Al-Azzawi H.H., Lu D., Swartz-Basile D.A., and Nakeeb A. Ezetimibe ameliorates cholecystosteatosis Surgery 142 2007 228 233 (Pubitemid 47198670)
37. Mok H.Y., von Bergmann K., and Grundy S.M. Effects of continuous and intermittent feeding on biliary lipid outputs in man: application for measurements of intestinal absorption of cholesterol and bile acids J Lipid Res 20 1979 389 398 (Pubitemid 9137746)
38. Kesäniemi Y.A., and Miettinen T.A. Cholesterol absorption efficiency regulates plasma cholesterol level in the Finnish population Eur J Clin Invest 17 1987 391 395 (Pubitemid 18063904)